Furthermore, the expression of cyclin B1 and cyclin D1 was increased in HepG2 cells with 500-ng/mL rhPGRN treatment as compared with the control (Fig. 3B), which suggests that PGRN has a growth-promoting effect on HCC cells. The gene discussed is CCND1; the disease is hepatocellular carcinoma.